GECO: Study to Investigate Genetic Causes of Severe Early Childhood Onset Obesity.
Study Details
Study Description
Brief Summary
This study aims to investigate genetic causes of early childhood obesity.
The investigators will enroll children and young adults with severe early onset obesity (BMI
99th percentile) diagnosed prior to 6 years of age. The investigators will ask questions about the health and eating behavior of the participants, and perform a brief physical examination. The investigators will collect saliva or blood to perform genetic testing from the participants and invite family members to enroll in the study.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
This is a clinical and genomic study designed to investigate monogenic causes of severe early childhood obesity.
Participatns with severe early onset obesity will be identified by screening of the clinical database or referred for the study. These subjects will be invited to participate in the study. After obtaining informed consent, the investigators will obtain history on the proband and the family, and perform a brief examination in addition to collecting genetic material.
Targeted sequencing of genes associated with monogenic and syndromic forms of obesity will be performed using next-generation sequencing. In selected individuals with favorable family history, exome or whole genome sequencing will be performed. Functional analysis of newly identified variants will be performed where possible.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Early-onset severe obesity The study will enroll children and young adults up to 21 years of age with early onset severe obesity (BMI > 99th percentile noted at an age < 6 years of age). |
Outcome Measures
Primary Outcome Measures
- Identification of known or novel genetic variants in genes that underlie obesity. [1.5-2 years]
Identification of known or novel genetic variants in genes that underlie obesity.
Secondary Outcome Measures
- Prevalence of melanocortin receptor 4 mutations. [2 years]
We will test the hypothesis that 1-3% of early onset obesity could be explained by carriage of mutation of monogenic obesity such as melanocortin receptor 4 in a mixed pediatric population.
Eligibility Criteria
Criteria
Inclusion Criteria:
- BMI > 99th percentile documented at age < 6 years of age
Exclusion Criteria:
-
Known genetic causes of obesity
-
Known Endocrine causes of obesity.
-
Neurologic tumor, trauma or surgery
-
Prior malignancy or transplant
-
Known autoimmune diseases
-
Edema of a known or unknown cause
-
Prolonged steroid use.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Vidhu Thaker | New York | New York | United States | 10032-3822 |
2 | Columbia University Medical Center | New York | New York | United States | 10032 |
Sponsors and Collaborators
- Boston Children's Hospital
Investigators
- Principal Investigator: Vidhu Thaker, M.D., Columbia University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- IRB-P00009351